Validation of a comorbidity questionnaire in patients with neurological disorders
Rational Several tools exist to assess comorbidities in neurological disorders, the most widely used being the Charlson Comorbidity Index (CCI), but it has several limitations. The Comorbidity and General Health Questionnaire (CGHQ) is a newly designed tool, which includes additional comorbidities a...
Main Authors: | Anette Schrag, Shree Vadera, Nirosen Vijiaratnam, Christine Girges, Katharina Lefringhausen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-10-01
|
Series: | BMJ Neurology Open |
Online Access: | https://neurologyopen.bmj.com/content/5/2/e000464.full |
Similar Items
-
Liquid Levodopa/Carbidopa: Old Solution, Forgotten Complication
by: Nirosen Vijiaratnam, et al.
Published: (2017-09-01) -
Neurological deficits and comorbidity in children with reading disorder
by: Sajida Naz, et al.
Published: (2019-10-01) -
Validity of the self-administered comorbidity questionnaire in patients with inflammatory bowel disease
by: Reinier Cornelis Anthonius van Linschoten, et al.
Published: (2023-10-01) -
Hysterical and comorbid mental disorders in outpatient neurological practice
by: L. V. Romasenko, et al.
Published: (2019-07-01) -
Validation of cognitive screening questionnaire for neurological disorders (CSQND) for screening of cognitive complaints among patients with multiple sclerosis
by: Amr Fouad, et al.
Published: (2022-08-01)